Eye of the Eagle
Table of Contents
01 October 1998
The Global 2000 River Blindness Program of the Carter Center Volume 10
From January to August 1998, Global 2000 River Blindness Program (GRBP)-assisted programs in the Americas, Cameroon, Nigeria, Sudan, and Uganda used ivermectin (Mectizan®, Merck & Co) to treat 4,900,321 persons. This represents 84% of the GRBP 1998 annual treatment objective for the eligible at risk population (ATOearp).